The future of LC-MS in epidemiology looks promising with advancements in technology and methodology. Potential developments include:
- Enhanced Sensitivity: Improvements in LC-MS technology will allow for the detection of even lower concentrations of analytes. - High-Throughput Analysis: Automation and high-throughput capabilities will enable the analysis of larger sample sizes, improving the robustness of epidemiological studies. - Integration with Other Omics Technologies: Combining LC-MS with genomics, proteomics, and other omics technologies will provide a more comprehensive understanding of disease mechanisms and epidemiology.
